SCHEMBL2013812

SCHEMBL2013812

CN(C(=O)c1n[nH]c2ccccc12)C(CCNC(=O)c1cccn1C)Cc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 2/20 0.59
HCRTR2 O43614 2/20 0.59
RAB9A P51151 4/20 0.48
SMN1; SMN2 Q16637 4/20 0.48
NPC1 O15118 3/20 0.48
ALDH1A1 P00352 1/20 0.48
TSHR P16473 1/20 0.43
KDM4E B2RXH2 2/20 0.43
ITK Q08881 2/20 0.42
MEN1 O00255 1/20 0.41
GAA P10253 1/20 0.41
KMT2A Q03164 1/20 0.41
HTR1A P08908 1/20 0.41
DRD2 P14416 1/20 0.41
HTR2A P28223 1/20 0.41
PADI4 Q9UM07 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2015628 0.91 HCRTR1 (0.57) HCRTR1HCRTR2RAB9ASMN1; SMN2NPC1
SCHEMBL2012866 0.89 HCRTR1 (0.59) HCRTR1HCRTR2RAB9ASMN1; SMN2NPC1
SCHEMBL2012867 0.89 HCRTR1 (0.59) HCRTR1HCRTR2RAB9ASMN1; SMN2NPC1
SCHEMBL2012839 0.86 HCRTR1 (0.59) HCRTR1HCRTR2RAB9ANPC1ALDH1A1
SCHEMBL2054164 0.84 HCRTR1 (0.61) HCRTR1HCRTR2RAB9ANPC1ALDH1A1
SCHEMBL2011905 0.84 HCRTR1 (0.61) HCRTR1HCRTR2RAB9ANPC1ALDH1A1
SCHEMBL2014186 0.83 HCRTR1 (0.60) HCRTR1HCRTR2RAB9ANPC1DRD2
SCHEMBL2012754 0.83 HCRTR1 (0.62) HCRTR1HCRTR2RAB9ANPC1ALDH1A1
SCHEMBL2015468 0.83 HCRTR1 (0.58) HCRTR1HCRTR2RAB9ANPC1PADI4
SCHEMBL2012204 0.83 HCRTR1 (0.58) HCRTR1HCRTR2RAB9ASMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO claimed
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO disclosed